Viewing Study NCT00140660


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-03-04 @ 8:46 PM
Study NCT ID: NCT00140660
Status: TERMINATED
Last Update Posted: 2017-03-13
First Post: 2005-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma
Sponsor: Lymphoma Study Association
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module